Through CYP17A1 inhibition, however, abiraterone acetate can cause cortisol deficiency with a state of excess of mineralocorticoids in a similar manner to 17-alpha hydroxylase deficiency in congenital adrenal hyperplasia (CAH). This evidence concerns the gene CYP17A1 and congenital adrenal hyperplasia.